Vaccine News and Research

Latest Vaccine News and Research

Live H5N1 avian flu virus vaccines show protection in animal studies

When tested in mice and ferrets, experimental vaccines based on live, weakened versions of different strains of the H5N1 avian influenza virus were well-tolerated and protected the animals from a deadly infection with naturally occurring H5N1 flu viruses.

12 Sep 2006

When inequality pays dividends

When there are limited treatments for serious diseases, such as bird flu and HIV-AIDS, city residents should be first in line for the drugs ahead of those in rural areas to most effectively contain the risk to the community, according to research led by a University of New South Wales (UNSW) academic.

12 Sep 2006

Unprecedented number of CDC staff resigned or retired in last two years

In the last two years, an "unprecedented" number of CDC staff has resigned or retired from the agency, prompting some officials to express concern, the Atlanta Journal-Constitution reports (Young, Atlanta Journal-Constitution, 9/10).

11 Sep 2006

Hand gel kills bird flu virus and Indonesian update

A company in the UK has come up with a hand gel which has the ability to kill the H5N1 bird flu virus in under a minute.

11 Sep 2006

Bavarian Nordic's modified Vaccinia Ankara patents infringed

The Administrative Law Judge at the U.S. International Trade Commission (ITC) issued his Initial Determination concluding that Acambis plc's smallpox vaccine product (MVA3000) infringes two of Bavarian Nordic's patents on Modified Vaccinia Ankara (MVA) and furthermore that Bavarian Nordic's patents are enforceable.

11 Sep 2006

Coalition drive to eradicate polio from Horn of Africa

Countries in the Horn of Africa are increasing their level of planning, coordination and streamlining their polio eradication strategies to cut the corridor of transmission of the poliovirus.

11 Sep 2006

Trial shows H5N1 vaccine safe and effective

A vaccine in development against the H5N1 influenza virus can produce a safe immune response in healthy people at low doses, according to an article published by The Lancet.

7 Sep 2006

NewYork-Presbyterian Hospital learning from 9/11

With the nation's busiest burn center and the metropolitan area's largest hospital Emergency Medical Services (EMS) fleet, NewYork-Presbyterian Hospital rescued and treated many survivors of the Sept. 11, 2001, attack on the World Trade Center.

7 Sep 2006

China appears to have beaten the world to a bird flu vaccine

Scientists in China have developed a potential vaccine against the deadly H5N1 bird flu virus currently sweeping across Asia.

7 Sep 2006

New assessment shows continued serious fuel and water shortages at Lebanese health facilities

A newly-published assessment of health facilities in Lebanon shows that a quarter of those examined are not functioning due to physical damage, lack of staff or lack of accessibility, and that water and fuel shortages remain a serious concern.

6 Sep 2006

Messy nappies may be sign of severe intestinal infection

Anyone who's ever cared for an infant or young child knows what it's like to change the occasional smelly, messy diaper.

5 Sep 2006

Needle-less immunisation is coming

Those of us who are squeamish about having an injection can take a sigh of relief: needle-less immunisation is coming our way according to new research revealed today at the British Pharmaceutical Conference in Manchester.

4 Sep 2006

New rapid diagnostic tests for Neisseria meningitidis

Over a million people each year, most of them in the "meningitis belt" in Africa, contract bacterial meningitis, a potentially deadly infection of tissues that line the brain and spinal cord.

4 Sep 2006

Sanofi pasteur begins shipping influenza vaccine

Sanofi pasteur, the vaccines business of the sanofi-aventis Group, began shipping influenza vaccine (Fluzone, Influenza Virus Vaccine) to the U.S. market for the 2006-2007 season.

4 Sep 2006

Cervical cancer vaccines offer broader cancer protection

Researchers now believe the first ever cervical cancer vaccine may provide even more protection against the killer disease than first thought.

4 Sep 2006

Vaccine for severe malaria

The most severe form of malaria hits pregnant women and children the hardest.

1 Sep 2006

The new landscape of neglected disease drug development

A recent report shows that drug development for killer diseases such as HIV/AIDS, TB, Malaria, Chagas and Sleeping Sickness has increased in recent years.

1 Sep 2006

Emergent BioSolutions awarded $3.8 million to develop anthrax immune globulin therapeutic

Emergent BioSolutions has announced that it has been awarded two grants from the National Institute of Allergy and Infectious Diseases (NIAID) totaling $3.8 million to support the development of the company's anthrax immune globulin (AIG) therapeutic product.

1 Sep 2006

Some parents have difficulties gaining access to insurance coverage for HPV vaccine Gardasil

Some parents seeking to vaccinate their daughters with Merck's human papillomavirus vaccine Gardasil have experienced difficulty in obtaining it or getting it covered by health insurance, the AP/Seattle Post-Intelligencer reports (Tanner, AP/Seattle Post-Intelligencer, 8/29).

1 Sep 2006

Morphotek granted two European technology patents

Morphotek has announced that the European Patent Office has given a "Decision of Grant" regarding the Company's US Patent 6,921,666 entitled "Methods for Generating Hypermutable Yeast" and US Patent 6,737,268 entitled "A Method for Generating Genetically Altered Antigens."

30 Aug 2006